ACH analyst estimates

Accendra Health (ACH) analyst ratings, the average price target and its range, and every firm's latest call.

ACH analyst ratings and price targets

DateFirmCallTarget
Aug 13, 2026UBSAccendra Health price target lowered to $1.50 from $4.50 at UBS$1.50
Aug 11, 2026Robert W. BairdBaird Downgrades Accendra Health Inc. (ACH) to Neutral$1.50
May 12, 2026Robert W. BairdAccendra Health price target raised to $6 from $5 at Baird$6.00
May 12, 2026UBSAccendra Health price target raised to $4.50 from $3 at UBS$4.50
Feb 22, 2026UBSAccendra Health price target lowered to $3 from $4 at UBS$3.00
Jan 6, 2026Robert W. BairdAccendra Health price target lowered to $5 from $7 at Baird$5.00
Nov 3, 2025UBSUBS Downgrades Owens & Minor (OMI) to Neutral$4.00
Aug 13, 2025UBSOwens & Minor price target lowered to $7 from $13 at UBS$7.00
Aug 11, 2025J.P. MorganTop Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings$10.00
Aug 8, 2025Robert W. BairdOwens & Minor upgraded to Outperform from Neutral at Baird$10.00
Nov 5, 2024Robert W. BairdOwens & Minor (OMI) PT Lowered to $14 at Baird$14.00
Sep 23, 2024Robert W. BairdBaird Reiterates Neutral Rating on Owens & Minor (OMI)$19.00
Jun 25, 2024Robert W. BairdOwens & Minor price target lowered to $20 from $24 at Baird$20.00
Jun 25, 2024Leerink PartnersOwens & Minor price target lowered to $17 from $21 at Leerink$17.00
May 6, 2024Robert W. BairdOwens & Minor (OMI) PT Lowered to $24 at Baird$24.00